Isolation, Purification, and Characterization of Amadoriase Isoenzymes (Fructosyl Amine-oxygen Oxidoreductase EC 1.5.3) from Aspergillus sp.*

(Received for publication, July 22, 1996, and in revised form, November 19, 1996)

Motoko Takahashi Dagger , Monika Pischetsrieder Dagger § and Vincent M. Monnier

From the Institute of Pathology, School of Medicine, Case Western Reserve University, Cleveland, Ohio 44106

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgment
REFERENCES


ABSTRACT

Four "amadoriase" enzyme fractions, which oxidatively degrade glycated low molecular weight amines and amino acids under formation of hydrogen peroxide and glucosone, were isolated from an Aspergillus sp. soil strain selected on fructosyl adamantanamine as sole carbon source. The enzymes were purified to homogeneity using a combination of ion exchange, hydroxyapatite, gel filtration, and Mono Q column chromatography. Molecular masses of amadoriase enzymes Ia, Ib, and Ic were 51 kDa, and 49 kDa for amadoriase II. Apparent kinetic constants for Nepsilon -fructosyl Nalpha -t-butoxycarbonyl lysine and fructosyl adamantanamine were almost identical for enzymes Ia, Ib, and Ic, but corresponding values for enzyme II were significantly different. FAD was identified in all enzymes based on its typical absorption spectrum. N-terminal sequence was identical for enzymes Ia and Ib (Ala-Pro-Ser-Ile-Leu-Ser-Thr-Glu-Ser-Ser-Ile-Ile-Val-Ile-Gly-Ala-Gly-Thr-Trp-Gly-) and Ic except that the first 5 amino acids were truncated. The sequence of enzyme II was different (Ala-Val-Thr-Lys-Ser-Ser-Ser-Leu-Leu-Ile-Val-Gly-Ala-Gly-Thr-Trp-Gly-Thr-Ser-Thr-). All enzymes had the FAD cofactor-binding consensus sequence Gly-X-Gly-X-X-Gly within the N-terminal sequence. In summary, these data show the presence of two distinct amadoriase enzymes in the Aspergillus sp. soil strain selected on fructosyl adamantanamine and induced by fructosyl propylamine. In contrast to previous described enzymes, these novel amadoriase enzymes can deglycate both glycated amines and amino acids.


INTRODUCTION

Nonenzymatic glycation of proteins has been implicated in the pathogenesis of diabetic complications as one of several mechanisms by which chronic elevation of glycemia may be responsible for the early cellular and extracellular dysfunctions triggered by diabetes. The Amadori product, which forms in the initial stages of the Maillard reaction in vivo, has been shown to be recognized by receptors at the surface of monocytes, aortic endothelial, and mesangial cells (1-3), and treatment of diabetic mice with antibodies to glycated albumin decreases the rate of progression of diabetic nephropathy (4). Amadori products of glucose are precursors of the glycoxidation products pentosidine and Nepsilon -(carboxymethyl)lysine (5-7), which are elevated in diabetes and the levels of which increase with the severity of diabetic complications (8-10). Furthermore, Nepsilon -(carboxymethyl)lysine has now been identified as the major advanced glycation end product (AGE)1 epitope (11) and is also likely to be responsible for the major negative charge in AGE proteins which appears to play a role for recognition by AGE receptors in macrophages or endothelial cells (12, 13). Amadori products and glycated proteins are able to generate free radicals, which may oxidize low density lipoproteins and form covalent cross-links with other proteins (14, 15).

Collectively, these data suggest that increased levels of Amadori product in diabetes may be responsible for much of the glucotoxicity underlying the pathogenesis of diabetic complications. Based on this premise, we began a few years ago to search for novel ways to selectively prevent the effects of protein glycation by attempting to deglycate proteins enzymatically (16), with the ultimate goal of utilizing such enzymes in transgenic models of hyperglycemia. We found and partially purified a deglycating enzyme in a Pseudomonas sp. soil strain selected for growth with glycated epsilon -aminocaproic acid as sole carbon source (17). Surprisingly, however, the enzyme obtained cleaved glycated substrates at the N-alkyl instead of the ketoamine bond and released free fructosamine, while the deaminated alkyl residue spontaneously oxidized to the acid.

We synthesized a highly sterically inhibited Amadori product using adamantanamine, and utilized this substrate as sole carbon source to select soil organisms. Two molecularly distinct isoenzymes were obtained from an Aspergillus sp., which can degrade both glycated low molecular weight amines and amino acids. The work described below provides a basis for the molecular analysis of deglycating enzymes and their biological mechanism of regulation.


EXPERIMENTAL PROCEDURES

Materials

N,O-Bis(trimethylsilyl)acetamide (BtmSA) was obtained from Fluka. Silica gel-coated aluminum thin layer chromatography plates (0.2 mm thick) were obtained from EM Separations (Gibbstown, NJ). alpha -Glucosone was a gift from Dr. Milton Feather (Department of Biochemistry, University of Missouri) or synthesized from the phenylosazone derivative (18) as described by Bayne (19). Adamantanamine and o-phenylenediamine (OPD) were purchased from Aldrich. Aminopropyl glass, poly-D-lysine, poly-L-lysine, phenylmethylsulfonyl fluoride (PMSF), EDTA, bovine serum albumin (BSA) (fraction V) and m-aminophenylboronic acid agarose were from Sigma. Glucosone triazine was a gift from Dr. Marcus Glomb. DEAE-Sepharose, Sephacryl S-200, and Mono Q were purchased from Pharmacia (Uppsala, Sweden). Bio-Gel HT hydroxyapatite was obtained from Bio-Rad. All other materials were analytical grade.

Synthesis of Glycated Substrates

Fructosyl adamantanamine was synthesized according to a modified protocol of Hodge and Rist (20). 5 g of adamantanamine, 3.8 g of glucose, and 10 ml of acetylacetone were heated in 100 ml of ethanol for 2 h under reflux. The solution was evaporated, and the residue was purified by silica gel column chromatography (17 × 2.5 cm, eluent: n-butanol/NH3, 10:1; monitored by TLC, eluent: ethanol/NH3, 10:1, RF = 0.4, detected with 0.2% ninhydrin in ethanol or 2% TTC in methanol, 1 N NaOH, 1:1). Fractions containing the product were pooled, evaporated, redissolved in water, and freeze-dried. The product identity was confirmed by 1H NMR: 1.36-1.70 (12H), 2.05 (3H), 3.31 (2H), and 3.52-3.56 (5H). Glycated BSA, poly-D-lysine (Mr 150,000-300,000), and poly-L-lysine (Mr 30,000-70,000) were prepared as follows: 15 mg/ml BSA, poly-D-lysine or poly-L-lysine was incubated in 50 mM HEPES (pH 7.4) containing M glucose, 1 mM DTPA, and 1 µl/ml chloroform and toluene for 5 days at 37 °C. The pH was monitored during incubation and adjusted by NaOH. The solution was dialyzed three times against water and freeze-dried. Glycated aminopropyl glass (Sigma) and Spherisorb-NH2 (Phenomenex) were prepared as follows; 50 mg/ml aminopropyl glass or Spherisorb was incubated in phosphate-buffered saline (PBS; 137 mM NaCl, 2.68 mM KCl, 1.47 mM KH2PO4, 8.06 mM Na2HPO4) containing M glucose, 1 mM DTPA, and 1 µl/ml chloroform and toluene for 24 h at 60 °C. The suspension was filtered and intensively washed with sterile water. Nepsilon -fructosyl Nalpha -t-Boc-lysine and Nalpha -fructosyl Nepsilon -acetyllysine were prepared according to Finot and Mauron (21). Fructosyl propylamine was prepared as follows; 30 g of glucose and 30 ml of propylamine were heated at 70 °C until the sugar was dissolved. The mixture was diluted in 200 ml of isopropanol and poured into 800 ml of diethyl ether. The precipitate was filtered and dissolved in 300 ml of boiling dioxane. 20 g of oxalic acid dissolved in 200 ml of dioxane was added, and the mixture was heated for 15 min at 70 °C. The precipitate was crystallized from dioxane/methanol (1:1), and oxalate was replaced by chloride by anion exchange chromatography. Fructosyl propylamine in reduced form was prepared as follows; 1.2 g of NaBH4 was added to 200 mg of fructosyl propylamine dissolved in 50 ml of water and incubated 12 h at room temperature. 1 ml of acetic acid was added to stop the reaction, and the solvent was removed under reduced pressure. 50 ml of methanol was added and evaporate to remove boronic acid. The residue was purified by Sephadex G-15 gel filtration column chromatography (eluent: PBS, detected with 0.2% ninhydrin in ethanol).

Microorganism and Culture Media

An Aspergillus sp. strain was isolated from soil by selection on minimal medium (3 g of KH2PO4, 7 g of K2HPO4, 0.1 g of (NH4)2SO4, 1 mM MgSO4 in 100 ml), containing fructosyl adamantanamine as sole carbon source (5.5 mg/ml). Solid media containing 2 g of agar/100 ml of medium were also prepared. The microorganism was isolated by alternate growth in liquid and on solid medium. Batch cultures were grown in nutrient broth containing 1 mg/ml fructosyl propylamine. Incubation was carried out at 37 °C for 3 days aerobically.

Preparation of an Enzyme-rich Fraction

To identify the reaction products, enzyme-rich fraction was prepared from Aspergillus sp. as follows. Mycel was harvested by filtration and washed by PBS. 750 mg (wet weight) of mycel was homogenized by using Potter-Elvehjem Teflon-glass homogenizer and by vortexing with 900 mg of glass beads in 300 µl of 20 mM sodium phosphate buffer, pH 7.4, containing 1 mM PMSF, 1 mM EDTA, and 2 mM DTT. The homogenate was centrifuged for 1 h at 100,000 × g, and the supernatant was brought to ammonium sulfate fractionation. The precipitation between 45% and 70% of ammonium sulfate was obtained by centrifugation at 15,000 × g for 15 min, redissolved in PBS containing 1 mM EDTA and 0.2 mM PMSF and diluted to a protein concentration of 8.0 mg/ml.

Identification of Enzymatic Degradation Products

The reaction products were identified by TLC and GC/MS. As a control an enzyme solution was heated for 15 min at 100 °C. For TLC 200 µl of the enzyme-rich fraction and 2 mg of Nepsilon -fructosyl Nalpha -t-Boc-lysine or fructosyl propylamine were incubated at 37 °C. After 1-4 days a sample was tested on TLC plates (eluent: n-butanol/acetic acid/water, 5:3:1, detection: 0.2% ninhydrin in ethanol or 2% TTC in methanol, 1 N NaOH, 1:1). As standards Nepsilon -fructosyl Na-t-Boc-lysine, fructosyl propylamine, glucosone, glucose, mannose, Nalpha -t-Boc-lysine, and propylamine were used. For GC/MS 8 µl of enzyme-rich fraction was incubated in 1 ml of PBS containing 15 mM fructosyl propylamine and 50 mM aminoguanidine for 24 h at 37 °C. The solution was filtered through a Microcon-10 (Amicon), and the filtrate was dried under vacuum (Savant, Farmingdale, NY). The residue was derivatized in 100 µl of pyridine/BtmSA (1:1) for 1 h at room temperature. Coupled gas chromatography and mass spectroscopy (GC/MS) were performed on a Hewlett-Packard 5890 series II gas chromatograph using helium as the carrier gas (flow rate 26.3 cm/s) on an Ultra 2 capillary column (25 m, 0.2 mm (inner diamter), film thickness 0.33 µm; Hewlett-Packard). Methane was used for positive chemical ionization. Injector and interface temperatures were 270 °C and 280 °C, respectively. Temperature program was 100-200 °C at 5 °C · min-1, 200-270 °C at 10 °C · min-1, and isothermal at 270 °C for 10 min. Glucosone triazine generously provided by Dr. Marcus Glomb was derivatized as above and used as a standard.

Assays for Enzymatic Activity

Four different assays were developed to measure the activity of the enzyme.

Glucosone Formation

For purification, the enzyme activity was monitored by the release of glucosone measured by a colorimetric reaction with OPD (22) using fructosyl propylamine as a substrate. This assay is based on the end point measurement of glucosone formed after 120 min of reaction time. The reaction mixture contained 20 mM sodium phosphate, pH 7.4, 10 mM OPD, 10 mM fructosyl propylamine, and enzyme protein in a final volume of 1 ml. After incubation at 37 °C for 2 h, the absorbance at 320 nm was measured. The reaction was linear to 240 min in a dose-dependent manner under these conditions. One unit of enzyme activity was defined as the amount of the enzyme that produces 1 µmol of glucosone/min. Synthesized glucosone was used as a standard.

Free Amine Assay

To assay the release of free amine, fluorescence was measured after reaction with fluorescamine. 25 µl of a solution of pure enzyme or enzyme-rich fraction, 15 µl of 20% fructosyl propylamine in water, and 250 µl of PBS were incubated at 37 °C for different times as indicated. The reaction was stopped by filtration through a Microcon-10 (Amicon, Beverly, MA) at 4 °C. 1 µl of the pure or 1:10 diluted filtrate was added to 1.5 ml of 50 mM phosphate buffer pH 8.0. Under vigorous vortexing 0.5 ml of 0.03% fluorescamine in dioxane was rapidly added. After 5 min fluorescence was measured (lambda ex = 390 nm, lambda em = 475 nm). A standard plot was made with 6-150 ng of propylamine.

H2O2 Assay

Hydrogen peroxide was quantitated by the quinone dye assay according to Sakai et al. (23). The reaction mixture contained 20 mM Tris-HCl, pH 8.0, 1.5 mM 4-aminoantipyrine, 2.0 mM phenol, 2.0 units of peroxidase, 10 mM fructosyl propylamine, and enzyme protein in a total volume of 1 ml. Production of the H2O2 was monitored by the formation of a quinone dye following the absorbance at 505 nm (epsilon  = 5.13 × 103). The production of 0.5 µmol of quinone dye corresponds to the formation of 1.0 µmol of H2O2.

Oxygen Consumption

Oxygen consumption was determined with a YSI-Beckman glucometer II equipped with a Clarke type oxygen electrode as described before (17). Briefly, enzyme (50 µl) was added to the chamber containing 750 µl of PBS and 650 µl of water. The reaction was started by addition of 50 µl of 300 mM fructosyl propylamine (final concentration 10 mM).

Purification of the Enzyme

All purification steps were carried out at 4 °C. Washed mycelia (180 g as wet weight) were suspended and homogenized in 900 ml of homogenizing buffer (20 mM sodium phosphate buffer, pH 7.4, 1 mM PMSF, 1 mM EDTA, 2 mM DTT) using a Polytron homogenizer (Kinematica, Littau, Switzerland) and Potter-Elvehjem Teflon-glass homogenizer. The homogenate was squeezed through the gauze and centrifuged at 20,000 × g for 30 min to remove unbroken cell and cell debris. The pellet was discarded, and solid ammonium sulfate was added to the supernatant to give 45% saturation. After stirring for 30 min, the mixture was centrifuged at 6,000 × g for 30 min. The supernatant was adjusted to 70% saturation by solid ammonium sulfate. After stirring for 30 min, the precipitate was obtained by centrifugation at 6,000 × g for 30 min and dissolved in a minimum volume of buffer A (20 mM Tris-HCl buffer, pH 8.0, 1 mM EDTA, 2 mM DTT) followed by dialysis against the same buffer. Insoluble material formed was removed by centrifugation at 20,000 × g for 15 min. The supernatant was applied to a DEAE Sepharose column (5 × 16 cm) equilibrated with buffer A. The column was washed extensively with buffer A, and the bound protein was eluted with a 3000-ml linear gradient of NaCl of 0-0.2 M in the same buffer. Fractions containing enzyme activity were pooled and dialyzed against 10 mM sodium phosphate buffer, pH 7.4, containing 1 mM EDTA, 2 mM DTT and applied to a hydroxyapatite column (1.5 × 4 cm) equilibrated with the same buffer. After washing the column extensively with the equilibration buffer, elution was carried out with a 140-ml linear gradient of sodium phosphate buffer, pH 7.4, over 10-100 mM, containing 1 mM EDTA and 2 mM DTT. Fractions with enzyme activity were pooled and concentrated with an Amicon Diaflow Ultrafiltration using PM 10 membrane (Amicon), and applied to a Sephacryl S-200 column (1 × 90 cm) equilibrated with 20 mM sodium phosphate buffer, pH 7.4, containing 150 mM NaCl, 1 mM EDTA, and 2 mM DTT, and eluted with the same buffer. The enzyme-active fractions were pooled, dialyzed against buffer A, and applied onto a Mono Q column (0.5 × 5 cm) equilibrated with buffer A. The column was washed with 4 ml of buffer A, and elution was carried out with a 20-ml linear gradient of 0-0.5 M NaCl in buffer A. Fractions containing enzyme activity were used as the purified preparation of amadoriases.

Protein Determination

Protein concentration was determined by the method of Bradford (24) with a Bio-Rad protein assay kit using BSA as a standard. Protein analysis by SDS-PAGE was carried out according to Laemmli (25). The molecular weight of native enzyme was determined by gel filtration on a Sephacryl S-200 column equilibrated with PBS containing 2 mM DTT using molecular weight markers (Sigma).

Kinetic Constants

Kinetic constants were calculated from the data by least-squares linear regression analysis.

Determination of pH Profiles and Isoelectric Points

pH profiles were determined over the range pH 5.8-9.5 using the following buffers: MES (pH 5.8-6.5), MOPSO (pH 6.5-7.5), POPSO (pH 7.5-8.5), and CHES (pH 8.5-9.5). Overlaps were used in all cases, and checks were made to ensure that none of the buffers were inhibitory and that the enzymes was stable during the time needed for the measurements. Isoelectric points were determined by isoelectric focusing using PhastGel IEF 5-8 (Pharmacia) and pI maker (IEF Mix 3.6-9.3, Sigma) in PhastSystem (Pharmacia).

Amino Acid Sequencing

N-terminal amino acid sequencing was performed at the Molecular Biology Core laboratory (Department of Biochemistry, Case Western Reserve University) with an Applied Biosystems 477A Protein Sequencer (Foster City, CA).


RESULTS

Search for an Amadori Product Degrading Microorganism and Identification of Deglycating Activity

Soil specimens were screened for a microorganism that can degrade Amadori products by using culture media with glycated substrates as sole carbon source. In order to increase the chances that the enzyme would also have activity against glycated proteins, Amadori products were chosen with a maximal steric hindrance at the amino side. As carbon sources glycated aminopropyl glass, glycated aminopropyl silica gel, glycated poly-D-lysine, and fructosyl adamantanamine were tested, but no organism could be isolated in presence of these substrates except fructosyl adamantanamine.

From the medium enriched with 5.5 mg/ml fructosyl adamantanamine, a microorganism was isolated and identified as an Aspergillus sp. strain. To ascertain the presence of Amadori product degrading activity, an extract of the fungus was produced and incubated with Nepsilon -fructosyl Nalpha -t-Boc-lysine. The reaction was monitored by TLC (Fig. 1) and compared with that of the heat-inactivated extract. In the course of the incubation the amount of the Amadori product in the extract was decreasing, whereas two new spots appeared on TLC. A ninhydrin-positive spot could be identified by comparison of the RF with an authentic standard as free Nalpha -t-Boc-lysine. The other spot reacted with TTC and co-migrated with synthetic glucosone. In the same way, free propylamine and glucosone derived from the reaction mixture of enzyme-rich fraction and fructosyl propylamine were observed (data not shown).


Fig. 1. TLC of time-course experiments. Reaction of enzyme-rich fraction and Nepsilon -fructosyl Nalpha -t-Boc-lysine. Enzyme-rich fraction was obtained as described under "Experimental Procedures." Plates were developed with ninhydrin (NIN) or TTC. In the course of 2 days, Nepsilon -fructosyl Nalpha -t-Boc-lysine was degraded and a TTC positive spot co-migrating with glucosone (Gln) and a ninhydrin-positive compound co-migrating with Nalpha -t-Boc-lysine (tBL) were formed.
[View Larger Version of this Image (20K GIF file)]


Identification of the Reaction Products

In order to confirm the molecular identity of the products, GC/MS analysis was performed after preparing the triazine derivatives with aminoguanidine and the trimethylsilyl derivatives with BtmSA. In the sample two major peaks appeared at retention times of 26.13 and 26.60 min, respectively (Fig. 2, top panel). The mass spectrum of both compounds showed characteristic peaks at m/z 342, 270, and 217 (Fig. 2A). A sample of authentic glucosone was derivatized in the same way with aminoguanidine and BtmSA and subjected to GC/MS analysis. The chromatogram showed peaks at 26.13 and 26.60 min for the two triazine stereomers, and the fragmentation patterns were identical to those of the degradation products (Fig. 2B). From the TLC and GC/MS data, it can be concluded that the enzyme releases glucosone and free amine from the Amadori product. Oxygen consumption during the reaction was detected polarographically using an oxygen electrode, and H2O2 generation was detected by the quinone dye assay (data not shown). Thus, all the data confirm that the Amadori product is degraded by an oxidative cleavage of the ketoamine bond, whereby oxygen is used as an electron acceptor and free amine and glucosone are released (Fig. 3).


Fig. 2. Identification of enzymatic reaction products of fructosyl propylamine. Aliquots of enzyme-rich fraction and fructosyl propylamine incubation in the presence of aminoguanidine were derivatized and analyzed by GC/MS as described under "Experimental Procedures." Top panel, total ion chromatogram of the sample incubation. A, mass spectra of the peak appeared at 26.60 min in the top panel. B, mass spectra of the synthetic glucosone triazine standard.
[View Larger Version of this Image (22K GIF file)]



Fig. 3. Proposed reaction mechanism for the formation of glucosone and H2O2 from glycated low molecular weight substrates in the presence of oxygen.
[View Larger Version of this Image (11K GIF file)]


Enzyme Assays and Time and Dose Dependence

Time-course experiments on the formation of glucosone detected as quinoxaline derivative by the OPD method were carried out with an enzyme-rich fraction incubated with fructosyl propylamine (Fig. 4). The amount of glucosone formed increased in the course of the incubation and with increasing enzyme concentration, proving thereby that an enzyme was responsible for the activity. A time-dependent release of free amine could be also found by free amine assay using fluorescamine (data not shown).


Fig. 4. Time- and dose-dependent release of glucosone from an incubation mixture of fructosyl propylamine and enzyme-rich fraction. 2 µl (bullet ), 4 µl (black-square), and 8 µl (black-triangle) of enzyme-rich fraction was used. Glucosone was quantified after reaction with OPD as described under "Experimental Procedures."
[View Larger Version of this Image (21K GIF file)]


Purification and Characterization of Four Enzyme Fractions

Since glucosone could be easily assayed by the OPD method, it was used for routine assays in the course of purification. Purification was performed as described under "Experimental Procedures." The extract was first fractionated by DEAE-Sepharose (Fig. 5A). Two peaks of amadoriase activity were observed. They were pooled into "pool 1" and "pool 2" and separately subjected to further purification. Fig. 5B shows the profile of the hydroxyapatite column chromatography of pool 1. Three peaks of activity were observed and purified individually by gel filtration and Mono Q column chromatography. Obtained enzymes were named amadoriase Ia, Ib, and II according to the order of elution from the hydroxyapatite column chromatography. Pool 2 was also subjected to hydroxyapatite column chromatography (Fig. 5C), and an active peak obtained was purified by gel filtration and Mono Q column chromatography. The enzyme obtained from pool 2 was named amadoriase Ic. Altogether four amadoriase enzyme fractions were isolated from Aspergillus sp. that had been selected with fructosyl adamantanamine and grown in the presence of fructosyl propylamine. The results of each purification of amadoriases are summarized in Table I. Each enzyme was purified to homogeneity as judged by Coomassie-stained SDS-PAGE (Fig. 6). The apparent molecular mass of amadoriase Ia, Ib, and Ic were found to be 51 kDa, and that of amadoriase II was 49 kDa. From the results of Sephacryl S-200 gel filtration, the apparent molecular masses of native amadoriases Ia, Ib, and Ic were calculated to be 40 kDa and II was 55 kDa (data not shown). The results indicated that all four enzymes were found to be monomers.


Fig. 5. Purification of amadoriase isozymes. Fractions at each purification step were assayed for glucosone formation activity as described under "Experimental Procedures." 10 mM fructosyl propylamine was used as a substrate. The arrows indicate the start of the elution. A, DEAE-Sepharose column chromatography. The fractions that were collected and used for further purification are marked by solid bars (pool 1 and pool 2). B, hydroxyapatite column chromatography of pool 1. The fractions marked by solid bars (Ia, Ib, and II) were collected and further purified to amadoriases Ia, Ib, and II, respectively. C, hydroxyapatite column chromatography of pool 2. The fractions marked by solid bar (Ic) were collected and further purified to amadoriase Ic.
[View Larger Version of this Image (28K GIF file)]


Table I.

Purification of amadoriases Ia, Ib, II, and Ic

Activity was measured by glucosone formation assay as described under "Experimental Procedures." 10 mM fructosyl propylamine was used as a substrate.
Step Total protein Total activity Specific activity Yield Purification

mg milliunits milliunits/mg % -fold
Amadoriase Ia
  Cell extract 846 160,000 190 100 1.0
  (NH4)2SO4 370 107,000 290 67 1.5
  DEAE-Sepharose (pool 1) 13.0 25,200 1900 16 10.0
  Hydroxyapatite 1 (peak Ia) 0.80 3080 3900 1.9 20.5
  Gel filtration 0.42 1850 4400 1.2 23.2
  Mono Q 0.14 659 4700 0.4 24.7
Amadoriase Ib
  DEAE-Sepharose (pool 1) 13.0 25,200 1900 16 10.0
  Hydroxyapatite 1 (peak Ib) 1.4 5430 3900 3.4 20.5
  Gel filtration 0.92 3860 4200 2.4 22.1
  Mono Q 0.42 1980 4700 1.2 24.7
Amadoriase II
  DEAE-Sepharose (pool 1) 13.0 25,200 1900 16 10.0
  Hydroxyapatite 1 (peak II) 2.8 5220 1900 3.3 10.0
  Gel filtration 2.2 4150 1900 2.6 10.0
  Mono Q 0.46 1140 2500 0.7 13.2
Amadoriase Ic
  DEAE-Sepharose (pool 2) 10.0 7800 780 4.9 4.1
  Hydroxyapatite 2 1.2 2100 1800 1.3 9.5
  Gel filtration 0.38 946 2500 0.6 13.2
  Mono Q 0.18 772 4300 0.5 22.6


Fig. 6. SDS-PAGE of purified amadoriases Ia, Ib, Ic, and II. Denatured protein was applied to a 10% homogeneous SDS-polyacrylamide gel and stained with Coomassie Brilliant Blue R-250. Each lane contained 0.3 µg of protein. The molecular mass of the marker proteins (M) were indicated in kDa.
[View Larger Version of this Image (62K GIF file)]


Substrate Specificity and Kinetic Constants of the Purified Amadoriases Ia, Ib, Ic, and II

Substrate specificity was examined for each purified enzyme (Table II). All four enzymes were active toward Nepsilon -fructosyl Nalpha -t-Boc-lysine as well as fructosyl propylamine. However, the relative activity of amadoriases Ia, Ib, and Ic toward fructosyl adamantanamine was low compared with that for fructosyl propylamine. They had no activity against Nalpha -fructosyl Nepsilon -acetyllysine. In contrast, amadoriase II was active toward fructosyl adamantanamine and Nalpha -fructosyl Nepsilon -acetyllysine. None of them were active toward reduced fructosyl propylamine (10 mM), glycated BSA (2 mg/ml), glycated poly-L-lysine (0.02%) or glucose (10 mM). Apparent kinetic constants for Nepsilon -fructosyl Nalpha -t-Boc-lysine and fructosyl adamantanamine are shown in Table III. The stoichiometry of the reaction catalyzed by the enzymes was determined using fructosyl propylamine as a substrate. Stoichiometric consumption of O2 and formation of H2O2 and glucosone was observed for each enzyme (data not shown).

Table II.

Substrate specificity of amadoriases

Activity was measured by glucosone formation assay as described under "Experimental Procedures" except that the reaction mixtures contained various kinds of substrates instead of fructosyl propylamine.
Substrates (10 mM) Specific activity (units/mg)
Amadoriase Ia Amadoriase Ib Amadoriase Ic Amadoriase II

Fructosyl propylamine 4.7  (100)a 4.7  (100) 4.3  (100) 2.5  (100)
Fructosyl adamantanamine 0.49  (10) 0.49  (10) 0.49  (11) 3.0  (121)
Nepsilon -Fructosyl Nalpha -t-Boc-lysine 4.3  (92) 4.4  (94) 4.5  (104) 4.8  (193)
Nalpha -Fructosyl Nepsilon -acetyllysine NDb 0.16  (3) 0.12  (3) 3.7  (151)

a  Activity is given as percentage in parentheses. The activity against fructosyl propylamine was taken as 100% for each enzyme.
b  ND, not detected.

Table III.

Kinetic constants of amadoriases

Activity was measured by glucosone formation assay as described under "Experimental Procedures" except that the reaction mixtures contained Nepsilon -fructosyl Nalpha -t-Boc-lysine or fructosyl adamantanamine as a substrate instead of fructosyl propylamine. Apparent kinetic constants were obtained by least-squares linear regression analysis of the data obtained under nonsaturating conditions. Values of the parameters are means ± S.D. (n = 5).
Amadoriase Nepsilon -Fructosyl Nalpha -t-Boc-lysine
Fructosyl adamantanamine
Km kcat kcat/Km Km kcat kcat/Km

mM min-1 M-1 min-1 mM min-1 M-1 min-1
Ia 3.0  ± 0.3 250  ± 13 0.8  × 105 14.4  ± 0.3 48  ± 1.3 3.3  × 103
Ib 3.1  ± 0.5 320  ± 32 1.0  × 105 14.7  ± 0.9 52  ± 1.7 3.5  × 103
Ic 3.3  ± 0.2 320  ± 12 1.0  × 105 14.7  ± 0.9 52  ± 1.7 3.5  × 103
II 1.6  ± 0.1 330  ± 5.8 2.0  × 105 3.4  ± 0.4 135  ± 6.5 4.0  × 104

Prosthetic Group

In order to obtain information on the nature of the cofactor, the absorption spectrum of amadoriase enzymes was recorded. Fig. 7 shows the absorption spectra of amadoriases Ib and II. Two major absorption bands were detected at 362 and 452 nm with a shoulder at about 474 nm in the visible region, indicating the presence of flavine as prosthetic group. The spectra of the other enzymes were essentially the same.


Fig. 7. Absorption spectra of purified amadoriases Ib and II. The spectra were recorded in 10 mM sodium phosphate and 0.15 M sodium chloride (pH 7.4). The protein concentration was 0.3 mg/ml.
[View Larger Version of this Image (18K GIF file)]


pH Optimum and Isoelectric Points

The pH optima for amadoriases Ia, Ib, and Ic were pH 8.0 and for amadoriase II was pH 8.5. The isoelectric points of enzymes Ia, Ib, Ic, and II were 5.5, 5.5, 5.7, and 6.7, respectively.

Amino Acid Sequencing

To identify the proteins, N-terminal sequencing was carried out using a gas-phase protein sequencer. The sequence of all four enzymes are shown in Table IV.

Table IV.

Amino acid sequence homology between the N-terminal sequence of amadoriases and sequences of other peptides

These data were obtained by a computerized search using the combined GenBankTM CDS translations/PDB/SwissProt/SPupdate/PIR data base. Numbers indicate the amino acid positions within each sequence. Conservative substitutions are indicated by (+). The data of amadoriases correspond to the N-terminal sequences obtained in the present work. Other sequences and their accession numbers are as follows: porcine DAO, D-amino acid oxidase from porcine kidney (Ref. 26), M16972; human DAO, D-amino acid oxidase from human kidney (Ref. 27), X13227; Fusarium sti35, sti35 stress-inducible protein from Fusarium oxysporum (Ref. 28), M33643; human p21, human p21 protein (Ref. 29), M19990; yeast 44.4kD, hypothetical 44.4-kDa protein in chromosomal I from Schizosaccharomyces pombe, Z54354.
Protein Sequences with residue nos.

Amadoriase Ia 1A P S I L S T E S S I (C/T) V I G A G T W G20
Amadoriase Ib 1A P S I L S T E S S I   I   V I G A G T W G20
Amadoriase Ic                 1S T E S S I   I   V I G A G T W G (C) (S)T A L20
Amadoriase II        1A V T K S S S L   L   I V G A G T W G  T   S T20
Porcine DAO                     3+   +   V I G A G . . G  .   S T A L17
Human DAO                     3+   +   V I G A G . . G  .   S T A L17
Fusarium sti35               71E S . I    +  + I G A G + . G  .   S . A87
Human p21              2T E . . +   +   V + G A G . . G  .   S17
Yeast 44.4kD                 44S S +   +   V I G A G . . G  C56
FAD enzymes (beta alpha beta -fold)                                  GG . . G


DISCUSSION

We have isolated and purified four amadoriase enzyme fractions from Aspergillus sp. One of the four enzymes described above (amadoriase II) was different from the other three based on its N-terminal amino acid sequence and enzymatic properties. Amadoriase Ia and Ib appear identical, and amadoriase Ic have Michaelis-Menten properties and substrate specificities similar to amadoriase Ia and Ib. The N-terminal amino acid sequence of enzyme Ic is similar to that of enzymes Ia and Ib, except for the truncation of the first five N-terminal amino acids, which may have resulted from partial proteolytic breakdown during isolation. Thus, taken together, the data suggest the presence of two distinct amadoriase enzymes in the isolated Aspergillus strain. These enzymes cleave glycated substrates under consumption of oxygen and release of H2O2 and glucosone in a reaction involving FAD as a cofactor. Thus, they should be classified as fructosyl amine-oxygen oxidoreductases (EC 1.5.3). We propose the trivial name "amadoriase."

Search for sequence homology with other known proteins using the combined GenBank CDS translations/PDB/Swiss Prot/SPupdate/PIR data base with 220,000 sequences revealed that none of these proteins had been described before. However, partial identity with D-amino acid oxidase from porcine (26) and human kidney (27), sti35 stress-inducible protein from Fusarium oxysporum (28), human p21 protein (29), and hypothetical 44.4-kDa protein in chromosomal I from Schizosaccharomyces pombe is apparent, especially for amadoriase Ic (Table IV). On close inspection, it turns out that all the enzymes have the consensus sequence for the ADP-binding beta alpha beta -fold common to all FAD and NAD enzymes (30). All have the hydrophobic residues that form the hydrophobic core between the beta -strands and the alpha -helix.

The novel amadoriase enzymes described in this work join the growing family of fructosyl amino acid oxidase enzymes that can deglycate low molecular weight substrates under regeneration of the free amine while producing H2O2 and glucosone. Table V summarizes the currently known deglycating enzymes. The first fully characterized enzyme was described by Horiuchi and colleagues (31) in Corynebacterium sp., followed by a similar enzyme from Aspergillus sp. by the same group (32). Both enzymes regenerate the free amino acid and produce H2O2 and glucosone. The first was obtained from soil using fructosyl glycine as sole carbon and nitrogen source. It is a dimeric protein with identical 44-kDa subunits, which degrades glycated amino acids with a Km value in the submillimolar range. It has also activity against D-erythropentulosylglycine and D-tagatosyllysine but not against glycated alkylamines, beta -amino acids, L-imino acids and D-amino acids, Nepsilon -fructosyl lysine, or epsilon -amino caproic acid. The Aspergillus enzyme was obtained from the soil Aspergillus sp.1005 whose spores were grown in a medium containing 1% fructosyl glycine. It is a dimeric protein of 83 kDa with identical 43-kDa subunits, i.e. similar to that of the Corynebacterium enzyme but significantly different from our strain. The fungal enzyme had activity against many glycated amino acids, including Nepsilon -fructosyl lysine, but, in contrast to the enzymes described in this work, had no activity against glycated alkylamines. The Km for fructosyl glycine was 2.2 mM, i.e. in the same range as for our enzymes. The inability of Horiuchi's enzymes to deglycate the Amadori products of alkylamines apparently relates to the selection method.

Table V.

Properties of currently known deglycating enzymes


Source Molecular weight Inducer Km (substrate) Products Cofactor Ref.

Corynebacterium sp. 88,000 Fructosyl glycine 0.74 mM (fructosyl glycine) H2O2 FAD (31)
(dimeric) 0.71 mM (fructosyl phenylalanine) Glucosone
Penicillium. Difructosyl lysine (39)
Aspergillus sp. 83,000 Fructosyl glycine 2.2 mM (fructosyl glycine) H2O2 FAD (32)
(dimeric) 220 mM (fructosyl methylamine) Glucosone
F. oxysporum 50,000 Nepsilon -Fructosyl lysine 0.22 mM (Nepsilon -fructosyl lysine) H2O2 FAD (23)
Glucosone
Aspergillus sp. 51,000 Fructosyl propylamine 3.1 mM (Nepsilon -fructosyl lysine) H2O2 FAD This paper
  (amadoriases Ia, Ib, and Ic) 14.7 mM (fructosyl adamantanamine) Glucosone
Aspergillus sp. 49,000 Fructosyl propylamine 1.6 mM (Nepsilon -fructosyl lysine) H2O2 FAD This paper
  (amadoriase II) 3.4 mM (fructosyl adamantanamine) Glucosone

Recently, Sakai et al. (23) isolated a fructosyl lysine oxidase from the fungus Fusarium oxysporum using Nepsilon -fructosyl Nalpha -Z-lysine as a sole nitrogen source. The monomeric enzyme has, like our enzymes, a molecular mass of 50 kDa. The Km for Nepsilon -fructosyl lysine was very low (0.22 mM), but little activity was observed against fructosyl valine. A small amount of activity against glycated poly-L-lysine but not against glycated protein was observed. In contrast to the two other enzymes of Horiuchi, fructosyl lysine oxidase had covalently bound FAD.

Finally, Genzyme scientists described in a European patent (33) the presence of deglycating enzymes in the bacterial groups Klebsiella and Corynebacterium, the fungi Acremonium and Fusarium, and the yeast genus Debaryomyces grown in media containing glycated butylamine as sole nitrogen source. All enzymes obtained generated glucosone and H2O2. One enzyme isolated from Debaryomyces vanrijiae had a Km of 80 µM for glycated butylamine, a pH optimum from 7.0 to 8.5, and highest stability between pH 5.0 and 7.5. Molecular weights of these enzymes are undetermined.

In spite of the failure to induce soil organisms to produce enzymes with activity against glycated proteins, the discovery of inducible amadoriase isoenzymes in our fungus, together with the reports above describing the presence of amadoriase enzymes in several genetically unrelated organisms such as prokaryotes, fungi, and yeast, raises the important question of the evolutionary significance of deglycating enzymes. Except for the Pseudomonas enzyme described earlier (17), whose isolation was recently described (34), all amadoriase enzymes that regenerate the intact amine also generate the highly reactive molecules glucosone and H2O2. In view of the growing number of data which directly implicate H2O2, oxidative stress, and Maillard reaction intermediates in diabetes (35, 36), the question thus arises as to whether amadoriase enzymes occur in human tissues. The sequence homology between amadoriase isoenzymes and mammalian D-amino acid oxidase suggests that deglycating or related enzymes could occur in the human. To our knowledge there has been no systematic investigation of that question, except for a previous short report, the conclusions of which were questioned (37, 38). Cloning of amadoriase cDNA, which is in progress in our laboratory, will provide important information for future research in the possible occurrence of fructosyl amino acid oxidase in mammalian tissues.


FOOTNOTES

*   This work was supported by grants from the American Diabetes Association and the Juvenile Diabetes Foundation, Grants EY07099 and AG05601 from the National Institutes of Health, and a fellowship of the Deutsche Forschungsgemeinschaft. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Both authors contributed equally to this work and should be considered as first author.
§   Present address: Institut für Lebensmittelchemie der Universität München, Sophienstr. 10, 80333 München, Germany.
   To whom correspondence should be addressed. Tel.: 216-368-6613; Fax: 216-368-0495; E-mail: vmm3{at}po.cwru.edu.
1    The abbreviations used are: AGE, advanced glycation end product; BSA, bovine serum albumin; BtmSA, N,O-bis(trimethylsilyl)acetamide; DTT, dithiothreitol; GC/MS, coupled gas chromatography-mass spectrometry; OPD, o-phenylenediamine; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; PMSF, phenylmethylsulfonyl fluoride; t-Boc, t-butoxycarbonyl; TTC, triphenyltetrazolium chloride; MES, 2-(N-morpholino)ethanesulfonic acid; MOPSO, 3-(N-morpholino)-2-hydroxypropanesulfonic acid; POPSO, piperazine-1,4-bis(2-hydroxypropanesulfonic acid) dihydrate; CHES, 2-(N-cyclohexylamino)ethanesulfonic acid.

Acknowledgment

We thank Anne Morrissey, Laboratory of Clinical Microbiology, University Hospitals of Cleveland, for help with the identification of the soil organism.


REFERENCES

  1. Salazar, R., Brandt, R., and Krantz, S. (1995) Biochim. Biophys. Acta 1266, 57-63 [CrossRef][Medline] [Order article via Infotrieve]
  2. Wu, V.-Y., and Cohen, M. P. (1994) Biochem. Biophys. Res. Commun. 198, 734-739 [CrossRef][Medline] [Order article via Infotrieve]
  3. Ziyadeh, F. N., and Cohen, M. P. (1993) Mol. Cell. Biochem. 125, 19-25 [Medline] [Order article via Infotrieve]
  4. Cohen, M. P., Sharma, K., Jin, Y., Hud, E., Wu, V.-Y., Tomaszewski, J., and Ziyadeh, F. N. (1995) J. Clin. Invest. 95, 2338-2345 [Medline] [Order article via Infotrieve]
  5. Grandhee, S. K., and Monnier, V. M. (1991) J. Biol. Chem. 266, 11649-11653 [Abstract/Free Full Text]
  6. Dyer, D. G., Blackledge, J. A., Thorpe, S. R., and Baynes, J. W. (1991) J. Biol. Chem. 266, 11654-11660 [Abstract/Free Full Text]
  7. Ahmed, M. U., Thorpe, S. R., and Baynes, J. W. (1986) J. Biol. Chem. 261, 4889-4894 [Abstract/Free Full Text]
  8. Sell, D. R., Lapolla, A., Odetti, P., Fogarty, J., and Monnier, V. M. (1992) Diabetes 41, 1286-1292 [Abstract]
  9. McCance, D. R., Dyer, D. G., Dunn, J. A., Bailie, K. E., Thorpe, S. R., Baynes, J. W., and Lyons, T. J. (1993) J. Clin. Invest. 91, 2470-2478 [Medline] [Order article via Infotrieve]
  10. Beisswenger, P. J., Moore, L. L., Brinck-Johnsen, T., and Curphey, T. J. (1993) J. Clin. Invest. 92, 212-217 [Medline] [Order article via Infotrieve]
  11. Reddy, S., Bichler, J., Wells-Knecht, K. J., Thorpe, S. R., and Baynes, J. W. (1995) Biochemistry 34, 10872-10878 [Medline] [Order article via Infotrieve]
  12. Vlassara, H., Brownlee, M., and Cerami, A. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 5588-5592 [Abstract]
  13. Esposito, C., Gerlach, H., Brett, J., Stern, D., and Vlassara, H. (1989) J. Exp. Med. 170, 1387-1407 [Abstract]
  14. Mullarkey, C. J., Edelstein, D., and Brownlee, M. (1990) Biochem. Biophys. Res. Commun. 173, 932-939 [Medline] [Order article via Infotrieve]
  15. Brownlee, M., Pongor, S., and Cerami, A. (1983) J. Exp. Med. 158, 1739-1744 [Abstract]
  16. Gerhardinger, C., Taneda, S., Marion, M. S., and Monnier, V. M. (1994) J. Biol. Chem. 269, 27297-27302 [Abstract/Free Full Text]
  17. Gerhardinger, C., Marion, M. S., Rovner, A., Glomb, M., and Monnier, V. M. (1995) J. Biol. Chem. 270, 218-224 [Abstract/Free Full Text]
  18. Richtmyer, N. K. (1963) Methods Carbohydr. Chem. 2, 127-131
  19. Bayne, S. (1963) Methods Carbohydr. Chem. 2, 421-423
  20. Hodge, J. E., and Rist, C. E. (1953) J. Am. Chem. Soc. 75, 316-322
  21. Finot, P. A., and Mauron, J. (1969) Helv. Chim. Acta 52, 1488-1495
  22. Kawakishi, S., Cheng, R. Z., Saito, S., and Uchida, K. (1994) in Maillard Reactions in Chemistry, Food, and Health (Labuza, T. P., Reineccius, G. A., Monnier, V. M., O'Brien, J., and Baynes, J. W., eds), pp. 281-285, Royal Society of Chemistry, London
  23. Sakai, Y., Yoshida, N., Isogai, A., Tani, Y., and Kato, N. (1995) Biosci. Biotech. Biochem. 59, 487-491 [Medline] [Order article via Infotrieve]
  24. Bradford, M. M. (1976) Anal. Biochem. 72, 248-254 [CrossRef][Medline] [Order article via Infotrieve]
  25. Laemmli, U. K. (1970) Nature 227, 680-685 [Medline] [Order article via Infotrieve]
  26. Fukui, K., Watanabe, F., Shibata, T., and Miyake, Y. (1987) Biochemistry 26, 3612-3618 [Medline] [Order article via Infotrieve]
  27. Momoi, K., Fukui, K., Watanabe, F., and Miyake, Y. (1988) FEBS Lett. 238, 180-184 [CrossRef][Medline] [Order article via Infotrieve]
  28. Choi, G. H., Marek, E. T., Schardl, C. L., Richey, M. G., Chang, S., and Smith, D. A. (1990) J. Bacteriol. 172, 4522-4528 [Medline] [Order article via Infotrieve]
  29. Stevens, C., W., Manoharan, H., and Fahl, W., E. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 3875-3879 [Abstract]
  30. Wierenga, R. K., Terpstra, P., and Hol, W. G. J. (1986) J. Mol. Biol. 187, 101-107 [Medline] [Order article via Infotrieve]
  31. Horiuchi, T., Kurokawa, T., and Saito, N. (1989) Agric. Biol. Chem. 53, 103-110
  32. Horiuchi, T., and Kurokawa, T. (1991) Agric. Biol. Chem. 55, 333-338
  33. Genzyme Limited (1993) European Patent 0526150A1, Application 92306844 (9)
  34. Saxena, A. K., Saxena, P., and Monnier, V. M. (1996) J. Biol. Chem. 271, 32803-32809 [Abstract/Free Full Text]
  35. Baynes, J. W. (1991) Diabetes 40, 405-412 [Abstract]
  36. Elgawish, A., Glomb, M., Friedlander, M., and Monnier, V. M. (1996) J. Biol. Chem. 271, 12964-12971 [Abstract/Free Full Text]
  37. Monnier, V. M. (1983) Clin. Chem. 29, 1997 [Medline] [Order article via Infotrieve]
  38. Lubec, G., Schmid, R., and Bartosch, B. (1989) Clin. Chem. 35, 2254 [Medline] [Order article via Infotrieve]
  39. Watanabe, N., Ohtsuka, M., Takahashi, S., Sakano, Y., and Fujimoto, D. (1990) Agric. Biol. Chem. 54, 1063-1064

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.